Cash flow provided by operations of $0.6 million in Q4 2024 and $0.9 million in the year ended December 31, 2024 2024 annual revenue of $24.2 million, compared ...

Superior Reports Full Year and Fourth Quarter 2024 Financial Results. Achieved critical milestones in Company transformation.

SG&A for the full year 2024 was $156.4 million, down 6.2% compared to $166.7 million in 2023, as a result of ongoing cost calibration discipline. SG&A for the twelve months ended December 31, 2024 was ...

Achieved record gross bookings of $65.8 million and revenue of $59.7 million in full-year 2024Signed 46 new customers in 2024 and expanded ...

For FY 2025, CompoSecure expects mid-single digit growth in both Net Sales and Adjusted EBITDA with sales momentum building through the year and includes payment of the new Resolute Holdings ...

Southland Holdings, Inc. ( NYSE: SLND) Q4 2024 Earnings Conference Call March 5, 2025 10:00 AM ET Alex Murray - Director of Corporate Development and Investor Relations Frank Renda - President and ...

This order from the Income Tax Appellate Tribunal (ITAT) Mumbai addresses cross-appeals filed by Nickunj Eximp Enterprises Pvt. Ltd. (the assessee) and the Additional Commissioner of Income Tax (ACIT) ...

Patodia Filaments Pvt Ltd., the Income Tax Appellate Tribunal (ITAT) Mumbai ruled that trading results and gross profits cannot be interfered with if the assessee provides sufficient evidence of ...

Detailed price information for Cytek Biosciences Inc (CTKB-Q) from The Globe and Mail including charting and trades.

Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) today announced financial results for its fourth quarter and year ended December 31, 2024. “We concluded another year of sales and EBITDA ...

Gross profit for the fourth quarter 2024 was $108 million or 49% ... The most directly comparable U.S. GAAP financial measure to adjusted EBITDA is net income (loss) and the most directly comparable ...